Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Individuals who are occasionally anxious, and eat when stressed, can have trouble maintaining an optimal weight
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
BPC-157 can remain viable for years in its freeze-dried form under optimal conditions, but once reconstituted the clock ticks quicklystorage becomes far more critical
NDMA (N-nitrosodimethylamine) A disinfection byproduct and probable human carcinogen, regulated in potable water reuse applications and effectively removed by BAC and advanced oxidation processes
US$ 23.00
US$ 23.63
US$ 29.08
US$ 27.19
US$ 25.33
US$ 23.53
US$ 20.25
US$ 29.93
US$ 22.44
US$ 20.67
US$ 23.47
